Flavonoids are secondary plant metabolites whose anticancer properties are
actually being studied from an epidemiological and pharmacological point of
view. They are believed to be implicated in the lower risk of some forms o
f cancer observed in Asian countries, due to their capacity to control cell
proliferation, to act on certain regulatory enzymes as protein kinases or
topoisomerases. Based on these precedents, three flavonols isolated from a
cytotoxic butanol extract from Retama sphaerocarpa Boissier have been asses
sed to study their topoisomerase I and II activity Two new rhamnazin glycos
ides were found to have the ability to stabilize thr cleavage complex human
DNA topoisomerase I at concentrations in the 100-250 muM range, acting as
topoisomersase I poisons.